Guidance of Organ-Specific Vascular Barrier Formation
Anne Eichmann
Yale School of Medicine, USA
More detail
Clonal Hematopoiesis at the Crossroads of Aging, Cancer, and Cardiovascular Disease
Peter Libby
Harvard Medical School, USA
More detail
Plenary Lecturers
"Tek Tok" - Discovery of Vascular Targets to Treat Ocular and Kidney Diseases
Susan Quaggin
Northwestern University, USA
More detail
Organ-Specific and Functional Specialization of Vascular Cells
Ralf H. Adams
Max Planck Institute for Molecular Biomedicine, Germany
More detail
Plenary Lecturers
CAP1 Binds to Resistin or PCSK9, Standing at the Nodal Point of Disease Clusters Such As Metabolic Syndrome, Fatty Liver, and Hypercholesterolemia and Cancer
Hyo-Soo Kim
Seoul National University, Korea
More detail
Pulmonary Hypertension and Marfan Syndrome
Issei Komuro
The University of Tokyo, Japan
More detail
Plenary Lecturers
The Intersection of Infection, Inflammation and Vascular Occlusion
Jane E. Freedman
University of Massachusetts Medical School, USA
More detail
Translating Lymphangiogenesis Mechanisms to Therapeutics
Kari K. Alitalo
University of Helsinki, Finland
More detail
Plenary Lecturers
Guidance of Organ-Specific Vascular Barrier Formation
Anne Eichmann
Yale University, USA
More detail
Cerebral Cavernous Malformation: From Mechanism to Therapy
Mark L. Kahn
University of Pennsylvania, USA
More detail
Plenary Lecturers
Endothelial Heterogeneity in Health and Disease
Donald M. McDonald
UCSF, USA
More detail
"Tek Tok" - Discovery of Vascular Targets to Treat Ocular and Kidney Diseases
Susan Quaggin
Northwestern University, USA
More detail
Plenary Lecturers
CV Risk Reduction with Diabetes Medications: In Search of the Holy Grail
Silvio Inzucchi
Yale University, USA
More detail
Heart Failure: Are We Winning?
John J. V. McMurray
University of Glasgow, UK
More detail
Plenary Lecturers
The Intersection of Infection, Inflammation and Vascular Occlusion
Jane E. Freedman
University of Massachusetts Medical School, USA
More detail
Normalizing the Tumor Microenvironment to Improve Cancer Immunotherapy: Bench to Bedside